5 Key Takeaways
-
1
Dr. Friedman advocates for personalized glaucoma care using genetics, patient-reported outcomes, and technology to tailor management to individual needs.
-
2
Around half of glaucoma patients in the US remain undiagnosed, highlighting a significant gap that advances in AI and imaging could help close.
-
3
Personalized care involves understanding the broader impact of glaucoma on patients' lives, beyond just preventing blindness.
-
4
Emerging technologies, such as virtual reality testing and hybrid care models, promise to enhance patient monitoring and treatment efficiency.
-
5
Genetic testing can identify at-risk individuals and inform tailored treatment strategies, moving towards a more individualized approach in glaucoma management.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
